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Abstract
Background: Targeting overlapping behavioral phenotypes in neurogenetic disorders can help elucidate
gene-behavior relationships. Fragile X syndrome (FXS) and autism spectrum disorder (ASD) have been studied as a
model for this approach, and important areas of phenotypic overlap and divergence have been documented.
However, few studies have examined how the manifestation of ASD-related phenotypes in FXS may change over
development, a question which has important implications for conceptualizing shared etiologies of these disorders
and their constituent phenotypes. The goal of this study was to characterize ASD phenotypes in boys and girls with
FXS across development, as well as to compare individual component phenotypes among boys with FXS and boys
with idiopathic ASD (ASD-O) over time.
Methods: Sixty-five boys and girls with FXS and 19 boys with ASD-O completed a battery of diagnostic, cognitive, and
language assessments at two time points (mean 2.5 years apart). Nonparametric tests assessed changes in diagnostic
classification in FXS over time, and hierarchical linear modeling and repeated measures assessed changes in individual
ASD symptoms in FXS over time. Additionally, ANCOVAs compared ASD symptom severity and component phenotypes
in boys with FXS-O, FXS-ASD, and ASD-O at both time points.
Results: Overall, ASD symptom manifestation for children with FXS significantly increased over time, and developmental
predictors varied based on the domain of symptoms assessed. The greatest degree of overlap was observed between
boys with FXS-ASD and ASD-O in the domain of reciprocal social communication across time points, whereas boys with
ASD-O demonstrated greater impairment in restricted and repetitive behaviors at the later time point.
Conclusions: ASD symptoms increased in FXS with age, and social language impairment emerged as a potential core
shared feature of FXS and ASD that may help elucidate underlying molecular genetic variation related to phenotypic
variance, and aid intervention planning for subgroups of children showing distinct phenotypes. Results highlight the
value of a developmental perspective, and longitudinal data in particular, in evaluating shared behavioral phenotypes
across genetic conditions, lending insight into underlying cognitive, neural, and genetic mechanisms associated with key
developmental phenotypes in ASD and FXS.
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Background
Since the development of psychiatric nosology, it has been
recognized that clinical symptoms are often shared across
categorically defined disorders. Consistent with clinical ob-
servations, multiple genome-wide analysis studies (GWAS)
have produced molecular evidence of shared genetic risk
factors in several psychiatric disorders [35, 50]. Clearly de-
fining phenotypes cutting across diagnostic boundaries may
help to clarify relationships between behavioral symptoms
and underlying biology with long-term implications for
individualized treatment; this approach has been proposed
as a primary direction for the future of psychiatric research
[29]. A critical consideration in such efforts is how psychi-
atric phenotypes may manifest differently across develop-
ment. Longitudinal research on disorders such as attention
deficit-hyperactivity disorder [52], Down syndrome [44],
and autism spectrum disorder (ASD; [14, 62]) demonstrate
changes in clinical symptoms and underlying neurobiology
across the lifespan, underscoring the importance of
examining development when characterizing symptom-
atology within and across different psychiatric disorders.
Yet, few studies have adopted a developmental perspective
when examining shared genetic liability across conditions.
This paper examines developmental changes in diagnostic
classification, symptom expression, and related abilities
in fragile X syndrome (FXS) and ASD, two complex neu-
rodevelopmental disorders with considerable phenotypic
overlap. At both behavioral and neurobiological levels,
FXS and ASD are characterized by atypical developmental
trajectories. Therefore, charting the dual paths of pheno-
typic development in each disorder can help to identify
markers of shared etiology throughout the lifespan, with
direct clinical, methodological, and theoretical implications.
ASD is characterized by social and communicative
impairments and restricted and repetitive behaviors or
interests [2]. Hundreds of copy-number variations (CNVs),
de-novo mutations, and individual loci conferring elevated
risk have been implicated in ASD [56]. Monogenic
disorders account for up to 20% of diagnosed cases of
ASD, the most common of which is FXS [63]. FXS is
caused by a Cytosine-Guanine-Guanine (CGG) repeat
expansion of over 200 in the promoter region of the
fragile X mental retardation 1 (FMR1) gene on the X
chromosome. This expansion leads to methylation of the
promoter and effective silencing of the FMR1 gene, result-
ing in significant reduction or loss of fragile X mental re-
tardation protein (FMRP), an essential protein for brain
development and, in particular, the regulation of synaptic
function (see [4], for review). Individuals with FXS present
with heterogeneous cognitive, language, social, and behav-
ioral deficits [1, 4, 6]. Additionally, over 90% of individuals
with FXS display some ASD symptoms [28].
This considerable phenotypic overlap, together with
recognition that ASD appears to arise from heterogeneous
molecular genetic causes, has prompted investigations of
FXS (along with other monogenic conditions overlapping
with ASD) as a paradigm for understanding gene-brain-
behavior relationships relevant to ASD symptomatology
in a simplified genetic context [7, 22, 54]. FMRP is an
inhibitor of dendritic translation, involved in the regu-
lation of synaptic development, plasticity, and activity,
making it a good candidate for involvement in symptoms
associated with ASD given evidence implicating synaptic
disruptions in ASD [45, 55]. Specifically, FMRP sup-
presses group 1 metabotropic (mGluR1, mGluR5) glu-
tamate receptor-regulated translation, thereby regulating
numerous genes implicated in ASD (i.e., NLGN3, NRXN,
SHANK3, PTEN, TCS2, and NF1; [5, 15, 59]). Of note,
inhibition of mGluR5 in the FXS mouse model has been
shown to normalize numerous abnormal synaptic, signaling,
electrophysiological, and behavioral phenotypes that overlap
with ASD [45]. Finally, reduced levels of FMRP in FXS have
also been shown to disrupt signaling pathways of neu-
rotransmitters implicated in ASD, such as dopaminergic
receptors [43], GABA [12], and 5-HT [30].
Detailed characterization of shared phenotypes in these
disorders is necessary to identify specific behaviors that
may map more directly onto common underlying biology
(i.e., endophenotypes). Family studies of ASD indicate that
endophenotypes segregate independently in unaffected
relatives, possibly reflecting unique genetic contributions
[38, 47]. Therefore, characterizing ASD phenotypes in the
context of a monogenic disorder such as FXS offers a
unique opportunity to identify endophenotypes related
to known genetic variation. Social deficits represent the
most consistent area of overlap between idiopathic ASD
and individuals with FXS with comorbid ASD (i.e.,
FXS-ASD) in both severity and quality [8, 31–33, 53].
For instance, Klusek et al. [33] found that boys with
idiopathic ASD and FXS-ASD demonstrated highly similar
pragmatic (i.e., social) language profiles that were not
accounted for by overall cognitive impairment. Further,
it has been reported that FMR1 premutation carriers
(i.e., CGG repeat length between 55 and 200) may evidence
higher rates of ASD [3, 18, 19, 57], though population-
based studies are still needed, and clinically unaffected
carriers also demonstrate subtle pragmatic difficulties
similar to those observed among unaffected relatives of
individuals with ASD [40]. Therefore, social language may
be a promising candidate ASD endophenotype con-
nected with FMR1-related variation.
Not all ASD phenotypes express similarly among indi-
viduals with FXS, and understanding such differences is
equally informative in determining common pathways
between the two disorders. For instance, within the domain
of restricted and repetitive behaviors (RRBs), careful
examination of the types of behaviors demonstrated across
groups (rather than overall frequency) indicated similar
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rates of lower level motoric RRBs in FXS and idiopathic
ASD but fewer higher order compulsive and repetitive
behaviors in individuals with FXS meeting criteria for
ASD [61]. A mix of similarities and differences has also
been reported in the biophysiological and neuroanatomical
profiles of ASD and FXS [27, 41, 46, 62]. Mapping areas of
convergence and divergence in FXS and ASD is therefore
essential for deconstructing the heterogeneity of ASD, iden-
tifying those phenotypes that may relate to FMR1, and
guiding clinical interventions for both disorders.
Adopting a developmental perspective in such efforts is
critical for accounting for phenotypic changes that occur
with children’s growth and maturation. Although pro-
nounced changes are known to occur in such core ASD
symptom domains as social communication over time,
few studies have examined the role of development in
studies of ASD symptom manifestation in FXS, despite
the fact that studies conducted at a single time point
have included considerable age ranges (5–60 years; [34]).
Existing findings from cross-sectional work suggests vari-
ation in the expression of phenotypes associated with ASD
in children with FXS at different ages and cognitive abilities
[25, 34, 42, 53, 58], whereas longitudinal approaches using
questionnaires or behavioral ratings suggest more stability
of ASD symptoms in FXS [13, 26, 51]. In the one longitu-
dinal study using a gold-standard clinical measure of ASD
symptoms, Hernandez et al. [28] found that approximately
one third of their FXS sample demonstrated inconsistent
ASD classification over time based on the administration of
the Autism Diagnostic Interview-Revised (ADI-R; [37]), a
comprehensive parent-interview, although this change
was not statistically significant. Therefore, further direct-
assessment evaluations of ASD phenotypes in FXS are
needed to evaluate key phenotypes that overlap and to
identify specific developmental factors that impact the
manifestation of ASD symptoms in FXS, in order to ad-
vance clinical, methodological, and theoretical approaches.
This study examined the developmental manifestation
of ASD phenotypes in FXS, drawing from comprehensive
longitudinal assessments of children with FXS and
idiopathic ASD (i.e., ASD-O) using gold-standard ASD
diagnostic measures, and standardized assessments of
cognition, structural language (i.e., vocabulary), and prag-
matic language. We aimed to (1) characterize trajectories
of ASD symptoms in FXS and predictors of ASD symp-
toms over time and (2) compare the type and severity of
symptoms and individual behaviors observed in boys with
FXS to a group of boys with ASD-O.
Methods
Participants
Participants included 65 children with FXS (31 male, 34
female) and 19 boys with ASD-O. Because FXS is a rare
disorder, 12 pairs of siblings were included in analyses to
maximize sample size (see Table 1 for participant char-
acteristics). All participants spoke English as their first
language and were screened for use of at least three-word
phrases. Inclusion criteria for boys with ASD-O included a
previous clinical diagnosis confirmed through direct
assessment with the Autism Diagnostic Observation
Schedule (ADOS; [36]) and/or the ADI-R [37], and no
known ASD-related monogenic disorders.
Procedures
At two time points (mean 2.5 years apart, range 1.15–
3.90 years) participants completed a battery of cognitive,
language, and ASD diagnostic measures. Because this
sample was selected to assess stability over time, only
participants with greater than one time point were included
in the analyses. Participants were recruited through adver-
tisements at genetic clinics and physicians’ offices, advocacy
groups, and participant registries. All participants provided
informed consent and the University of North Carolina at
Chapel Hill (IRB #07-0044) and Northwestern University




Participants were administered the ADOS and the ADI-R.
The ADOS is a standardized, semi-structured assessment
that includes a range of activities designed to elicit social
interaction and consists of four different modules that
account for differences in developmental level and
language abilities. The ADOS determined ASD classi-
fication for children with FXS and confirmed ASD
classification for boys with ASD-O. Classification was
based on revised algorithms of the ADOS, and con-
tinuous symptom severity scores were also determined
[20, 21]. Consistent with DSM-5 [2], participants with
FXS that met either “spectrum” or “autism” criteria on
the ADOS were classified as FXS-ASD. The ADOS
consists of a range of individual items rated on a scale
of 0–3 (absent–severe). In order to compare perform-
ance on items across modules, codes that were identi-
cal or tapping the same symptoms across modules
were identified and used in item-level analyses. For
these analyses, items rated an 8 or 9 (i.e., a code was
not applicable or there was an administration error)
were reduced to 0, consistent with algorithm coding.
The ADI-R is a parent interview that assesses early
developmental features and provides an algorithm to
determine ASD classification. The ADI-R was
administered to confirm ASD in participants with
ASD-O and to examine classification agreement with
the ADOS in individuals with FXS over time.
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Cognitive and language abilities
The Leiter International Performance Scale-Revised [49]
provided an estimate of nonverbal mental age. The Ex-
pressive Vocabulary Test (EVT; [60]) and Peabody Picture
Vocabulary Test-3rd or 4th edition (PPVT; [16, 17]) were
used to assess expressive and receptive language. To assess
pragmatic language, participants completed the Pragmatic
Judgment subtest of the Comprehensive Assessment of
Spoken Language (CASL; [9]), which evaluates awareness
of appropriate language use in various social situations
(e.g., how to greet an unfamiliar adult or how to give an
appropriate compliment).
Analysis plan
The first aim of this study was to characterize trajectories
of ASD symptoms in FXS and predictors of ASD symp-
toms over time. McNemar’s test of classification assessed
whether rates of ASD and agreement between ADOS and
ADI-R changed over time. Nonparametric Wilcoxon
signed-rank tests were used to assess changes in indi-
vidual ADOS items across time points. These analyses
were run separately by sex and also within the group
of boys and girls with FXS who demonstrated a change in
ASD classification on the ADOS. Finally, hierarchical linear
models, nesting age within participant, were completed to
assess the statistical effect of chronological age, sex, mental
age, receptive and expressive vocabulary, and pragmatic
judgment age equivalence on measures of symptom
severity derived from the ADOS across time points. To
reduce collinearity among predictors, all predictor variables
in these models were mean-centered and expressive
and receptive vocabulary measures were combined into
a composite by summing the raw score on each measure.
The second aim of this study was to compare the
severity and type of ASD symptoms in boys with FXS
to a group of boys with ASD-O at each time point.
ANCOVAs, controlling for mental age and receptive
and expressive vocabulary age equivalence, followed by
planned comparisons, compared ASD severity scores as
well as individual items at both time points for boys classi-
fied as FXS-O, FXS-ASD, and ASD-O. Although item-
level scores are ordinal in nature, this parametric statistical
approach was chosen in order to include mental age and
vocabulary as covariates. Thus, results of item-level com-
parisons should be interpreted cautiously.
Results
Aim one: characterize trajectories of ASD symptoms in
FXS and predictors of ASD symptoms over time
Overall, 41.7% of children with FXS met criteria for ASD
at time one (54.8% of boys, 41.5% of girls); at time two,
60% of the sample met criteria (80.6% of boys, 41.2% of
girls), a statistically significant change (p = .008), driven by
the change in classification in boys with FXS (p = .021).
There was a nearly significant increase in ADI-R and
ADOS agreement over time (p = .065), driven by a signifi-
cant increase in agreement for boys with FXS (45.2 to
75%, p = .039), whereas agreement for girls with FXS
decreased slightly (73.5 to 64.7%, p = .45).
Table 1 Overall sample characteristics at time 1 and time 2









FXS-girls 34 8.96 (3.39) 6.18 (1.72)a 6.95 (2.67)a 7.40 (3.06)a 14 M2, 20 M3
FXS-O 24 8.50 (3.37) 6.51 (1.87) 7.32 (2.75) 7.90 (3.12) 11 M2, 13 M3
FXS-ASD 10 9.11 (3.14) 5.39 (.99) 6.05 (2.40) 6.98 (3.81) 3 M2, 7 M3
FXS-boys 31 8.97 (2.51) 4.77 (.69)b 4.69 (1.23)b 5.46 (1.53)b 2 M1, 18 M2, 11 M3
FXS-O 14 8.47 (2.58) 4.79 (.75) 4.51 (2.57) 5.19 (1.43) 1 M1, 8 M2, 5 M3
FXS-ASD 17 9.38 (2.45) 4.75 (.66) 4.84 (1.21) 5.67 (1.62) 1 M1, 10 M2, 6 M3
ASD (boys) 19 9.08 (2.31) 5.82 (1.43)b 5.79 (1.62)b 5.85 (1.71)b 2 M2, 11 M3









FXS-girls 34 11.21 (3.31) 7.31 (3.04)a 8.50 (2.95)a 9.48 (3.55)a 2 M2, 31 M3, 1 M4
FXS-O 20 11.98 (3.44) 8.12 (3.60) 9.61 (2.84) 10.88 (3.49) 20 M3
FXS-ASD 13 10.12 (2.88) 6.06 (1.18) 6.88 (2.35) 7.33 (2.46) 2 M2, 11 M3, 1 M4
FXS-boys 31 11.50 5.01(.50)b 5.36(1.27)b 6.15(1.51)b 5 M2, 26 M3
FXS-O 6 10.78 (1.65) 5.17 (.73) 6.06 (1.50) 6.71(.64) 6 M3
FXS-ASD 25 11.67 (2.5) 4.98 (.44) 5.19 (1.18) 6.02 (1.64) 5 M2, 20 M3
ASD (boys) 19 11.38 (2.63) 6.93(1.84)b 6.79 (2.14)b 7.68(2.11)b 2 M2, 17 M3
Differing superscripts indicate groups which significantly differed overall (p < .05). “M” represents ADOS module type. Italicized data indicate overall means by sex.
FXS-O and FXS-ASD group classification changed over time based on behaviors observed during the ADOS. Five participants with FXS had missing covariate data
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Repeated measure analyses were then conducted for
individual items on the ADOS. Boys with FXS overall
demonstrated increased impairments in the area of
shared enjoyment (Z = −2.57, p = .010) and social overtures
(Z = −2.71, p = .007), and girls with FXS demonstrated an
increase in impairments in prosodic features of speech
(Z = −2.42, p = .016), facial expressions (Z = −2.04, p = .041),
and social overtures (Z = −2.71, p = .05). No other signifi-
cant changes were noted on any other item in these groups
(Zs > −1.90, ps > .05). Item level analyses were replicated
within the group of participants who did not meet ASD
criteria at time one but did at time two in order to assess
symptoms that worsened with time. Within this group,
several algorithm items (i.e., items that would contribute
to a classification change) increased in impairment: con-
versation (Z = −2.1, p = .035), facial expressions (Z = −2.31,
p = .021), social overtures (Z = −2.95, p = .003), social
response (Z = −2.83, p = .005), and quality of rapport
(Z = −2.11, p = .035). In addition, impairment on a
non-algorithm item, atypical qualities of speech (Z = −1.98,
p = .048) also increased. No other significant changes were
noted (Zs > −1.83, ps > .068).
Hierarchical linear models revealed a significant main ef-
fect of age, in that greater age was associated with greater
symptom severity for all measures of severity (see Table 2).
Additionally, pragmatic competence was marginally associ-
ated with reduced overall severity and severity of social
affect (i.e., for every year increase in pragmatic language age
equivalence, predicted overall symptom severity decreased
by .34 and severity of social affect decreased by .32). In con-
trast, for restricted and repetitive behaviors, mental age sig-
nificantly predicted decreases in severity (i.e., for every year
increase in age equivalence, severity decreased by .38).
Aim two: comparisons of symptom severity and
type of ASD symptoms in boys with FXS and ASD-O
over time
At time one, overall ASD symptom severity and severity
of social impairment and RRBs in boys with FXS-ASD
were nearly indistinguishable from boys with ASD-O
(ps > .50; see Figure 1), and significantly greater than
boys with FXS-O (F(2,43) = 33.57, p < .001; F(2,43) =
23.81, p < .001; F(2,43) = 7.36, p = .002). At time two, a
stepwise pattern was observed in which boys with ASD-O
demonstrated significantly greater overall severity (driven
by more severe RRBs) than boys with FXS-ASD, who in
turn displayed greater severity than boys with FXS-O
(F(2,44) = 30.55, p < .001; F(2,44) = 6.86, p = .003). Boys
with ASD-O did not differ from boys with FXS-ASD on
severity of social impairment at time two (p = .26), and
Table 2 Main effects of hierarchical linear models
Test
Overall severity
Chronological age F(1,88.41) = 17.31, p < .001
Sex F(1,64.60) = .00, p = .98
Chronological age*sex F(1,104.92) = .404, p = .53
Mental age F(1,102.26) = 1.59, p = .211
Receptive and expressive vocabulary F(1,109.50) = .142, p = .71
Pragmatic language F(1,114.85) = 3.81, p = .054
Severity of social affect
Chronological age F(1,85.7) = 17.03, p < .001
Sex F(1,64.21) = .07, p = .80
Chronological age*sex F(1,101.32) = .43, p = .51
Mental age F(1,98.02) = .49, p = .49
Receptive and expressive vocabulary F(1,106.74) = .35, p = .56
Pragmatic language F(1,115.88) = 3.45, p = .07
Severity of restricted and repetitive behavior
Chronological age F(1,83.67) = 6.36, p = .014
Sex F(1,66.56) = .019, p = .87
Chronological age*sex F(1,96.37) = 1.65, p = .20
Mental age F(1,92.45) = 4.78, p = .03
Receptive and expressive vocabulary F(1,102.35) = .02, p = .89
Pragmatic language F(1,115.17) = 3.06, p = .08











































































Fig. 1 Comparison of ASD symptom severity of boys with FXS-O,
FXS-ASD, and ASD-O at each time point. Notes: ADOS severity derived
from Gotham et al. [21]. Differing letters convey significant differences
at the level of p < .05. Means are adjusted for nonverbal mental
age, expressive vocabulary, and receptive vocabulary
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both were significantly greater than boys with FXS-O
(F(2,44) = 17.98, p < .001).
Figures 2 and 3 demonstrate profiles of performance on
individual ADOS items across boys with FXS-O, FXS-ASD,
and ASD-O. At time one, groups did not differ in items
tapping prosodic features of speech, shared enjoyment,
imagination, sensory seeking behaviors, repetitive motor
movements, self-injury, overactivity, negative behavior, or
anxiety (F(2,41) < 2, ps > .05). However, several significant
group differences emerged (overall model F(2,41) > 3.7,
ps < .05). Boys with ASD-O and FXS-ASD demonstrated
overlap in conversation, eye contact, quality of social over-
tures and responses, amount of reciprocal communication,
and overall quality of rapport (ps > .05), and significantly
greater impairment than boys with FXS-O across these
domains (ps < .05). Boys with ASD-O demonstrated greater
impairments in restricted interests, gestures, and echolalia
relative to both FXS-ASD and FXS-O groups (ps < .05),
who did not differ from one another (ps > .07), and boys
with ASD also demonstrated greater impairments in
facial expressions and stereotyped speech than boys
with FXS-O only (ps < .03).
At the second time point, groups did not differ on items
tapping echolalia, gestures, shared enjoyment, imagination,
sensory seeking behaviors, repetitive motor movements,
self-injurious behavior, overactivity, negativity, or anxiety
(F(2,44) < 2.9, ps > .06); group differences emerged on the
remaining items (overall F(2,44) > 3.3, ps < .05). Boys with
FXS-ASD and ASD-O did not differ from each other
(ps > .06), and both demonstrated greater impairment
than boys with FXS-O in the domains of prosodic features
of speech, conversation, eye contact, quality of social re-
sponse, amount of reciprocal social interactions, and overall
quality of rapport (ps < .05). A stepwise pattern was
observed for facial expressions and social overtures in
which boys with FXS-O demonstrated less impairment
than boys with FXS-ASD, who in turn demonstrated
less impairment than boys with ASD-O (ps < .05). Finally,
boys with ASD-O demonstrated greater impairments in
stereotyped speech and restricted interests than boys with
FXS-ASD and FXS-O (ps < .01).
Discussion
This study applied a longitudinal lens to characterize
ASD symptom profiles in the context of FXS and identify
potential overlapping endophenotypes in ASD and FXS
across development. Findings suggest ASD symptoms
worsen with age and that this increase is most prominently
observed in social communication skills. Substantial
phenotypic overlap, as well as key areas of difference,
was observed in boys with ASD-O and FXS-ASD at
both time points.
In contrast to prior longitudinal reports (e.g., [26, 28]),























Fig. 2 Profile of ASD phenotypic expression on ADOS items at time one. Notes: Significant differences are reported in text. After accounting for
mental age, and receptive and expressive vocabulary, males with FXS-ASD and ASD-O demonstrated overlap on several items tapping social
communication, whereas individuals with ASD-O demonstrated greater impairment in restricted interests, gestures and echolalia
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time, with both classification and symptom severity sig-
nificantly increasing over time. This study was the first
to use the ADOS to examine changes over time; it may
be that direct assessments of behavior better capture
phenotypic variation contributing to diagnostic status
than parent report, in line with Harris et al. [24] finding
that the ADOS classifications were most consistent with
DSM-IV diagnoses. Of note, Klusek et al. [34] examined
ADOS and ADI-R agreement in a cross-sectional sample
overlapping with the current study and thus similar agree-
ment rates are not surprising. Rather, findings from the
current study build on this prior work by suggesting that
agreement increases with age, particularly for males with
FXS. Consistent with prior work showing that ASD is
more common in males than females with FXS [11, 23, 34],
girls with FXS in the current sample continued to demon-
strate reduced rates of ASD classification relative to boys
over time, although sex did not impact rates of change over
time when controlling for mental age and structural lan-
guage. Whereas studies should continue to investigate the
role of assessment approach and sex in observed changes
in symptoms over time, findings demonstrating an increase
in ASD symptoms with age have important implications for
long-term intervention planning for children with FXS, as
well as future research examining overlapping profiles of in-
dividuals with ASD and FXS.
The longitudinal approach of this study also allowed
for analyses of developmental features related to ASD
symptoms in individuals with FXS over time. The roles
of nonverbal mental age, structural language (i.e., receptive
and expressive vocabulary) abilities, and pragmatic compe-
tence in ASD symptom presentation in FXS changed as a
function of the domain assessed. For example, when
examining the significance of mental age in predicting
symptom severity, significant relationships emerged for se-
verity of restricted and repetitive behaviors, consistent with
prior findings from cross-sectional work [42, 58] and group
comparisons at a single time point (e.g., [23]). However,
mental age did not predict severity of social-affective symp-
toms. Thus, while general cognition remains an important
consideration when examining the expressions of ASD phe-
notypes in FXS, lower mental age does not appear to ac-
count for ASD symptoms in FXS entirely. Instead, variation
in pragmatic competence was the only significant covariate
in the model examining predictors of severity of social
affect over time, further suggesting the importance of prag-
matic development in observed impairments in FXS.
The language demands of the assessment context may
also play a role in observed ASD symptoms in FXS. In
fact, whereas at baseline approximately 50% of individuals
with FXS received a module 2 of the ADOS (a version that
is less linguistically demanding), with development of
language over 80% of individuals with FXS received a
module 3 at the later time point. That is, assessments
administered at time one involved limited expressive
language requirements whereas assessments at time
two entailed a heavier emphasis on expressive language
ability and reciprocal conversation (i.e., ADOS module
change). Therefore, the development of language abilities
may afford more observable manifestations of ASD-related
social and communicative deficits in children with FXS.
Interestingly, in the subgroup of children with FXS who
demonstrated a change in classification over time, the phe-
notypes driving this change were primarily related to social
interaction, including conversation, amount of reciproca-





















Fig. 3 Profile of ASD phenotypic expression on ADOS items at time two. Notes: Significant differences are reported in text. After accounting for
mental age, and receptive and expressive vocabulary, males with FXS-ASD and ASD-O demonstrated overlap on several items tapping social
communication, whereas individuals with ASD-O demonstrated greater impairment in restricted interests
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impairments emerged as a core shared phenotype across
boys with FXS-ASD and ASD-O, with highly similar levels
of social affective severity as well as several items linked to
social interactions (e.g., social overtures and responses)
observed in both children with FXS-ASD and ASD-O
across time points. These findings add to a growing
body of work demonstrating that communication [31]
and reciprocal social behaviors are shared across FXS-
ASD and ASD-O [8, 31, 32], predict later ASD classifi-
cation [48], and align in particular with literature show-
ing a high degree of pragmatic impairment overlap in
FXS-ASD and ASD-O [33, 40] as well as similarities in
pragmatic language profiles documented among rela-
tives who are genetic carriers [39]. An important next
step will be to continue to investigate mechanisms
underlying this overlap across groups; for example,
Roberts et al. [48] found that differential HPA axis acti-
vation (i.e., a measure of the body’s response to stress) im-
pacted social approach behaviors in individuals with FXS
with and without comorbid ASD. Such investigations, tar-
geting specific aspects of social behaviors across develop-
ment, hold promise for continuing to elucidate ASD
endophenotypes related to FMR1 variation.
Some important differences between boys with ASD-O
and FXS-ASD also emerged across time points. For
example, the FXS-ASD group did not differ in severity
of RRBs at time one but did differ at the later time
point. Important to note is that this difference was
driven by the fact that boys with ASD-O demonstrated
significantly greater impairments in restricted interests
(a higher order RRB) in particular. This difference may
therefore have been influenced by a distinct profile of
RRBs in FXS-ASD relative to ASD-O, as reported in
prior work [61, 62], and that may be more clearly observed
with age. Further, males with ASD-O demonstrated signifi-
cantly greater impairments than those with FXS-ASD on
symptom domains tapped by the ADOS that varied across
time points, in that at time one, but not at time two, boys
with ASD-O demonstrated greater rates of gestures and
echolalia. Such findings affirm that ASD in FXS is not iden-
tical to that observed in ASD-O, that age is likely to influ-
ence manifestation of this overlap, and that specific target
behaviors, such as social responses, may best map onto
underlying shared genetic etiology.
Together, results suggest that ASD as it presents in
FXS is not identical to idiopathic ASD. Given the clinical
and etiologic complexities of each disorder, this is not
necessarily surprising, nor should it undermine the utility
of studying FXS and other monogenic conditions as models
for understanding ASD related phenotypes. In line with
recent conceptualizations of psychiatric nosology, and
complementary findings from psychiatric genomics, current
findings strongly suggest that mapping homogeneous sets
of phenotypes cutting across disorders (and ultimately,
related underlying neural and molecular mechanisms,
and their interplay with environmental influences) is
crucial to understanding the pathogenesis of complex
psychiatric disorders such as ASD [10, 29]. Findings
here suggest that adopting a developmental framework
in such comparisons can provide necessary sharpened
focus to the analysis of complex phenotypes across disor-
ders. In the case of FXS and ASD, it appears that social-
communicative behaviors may be particularly fruitful
targets for biological study and clinical intervention,
where shared phenotypes can serve as a basis for trans-
lating new findings and treatments across disorders to
inform clinical and research practice.
Conclusions
Current findings highlight the importance of adopting a
developmental perspective when investigating shared
behavioral features across disorders. Including assessments
across multiple time points allowed for the identification of
overlapping and divergent phenotypes across two complex
neurodevelopmental disorders and clarification for the role
of related abilities in observed symptoms over time, with
key implications for understanding etiologic mechanisms
related to shared phenotypes across ASD and FXS, and im-
plications for clinical intervention. Incorporating a develop-
mental perspective within a shared phenotype approach
will continue to inform the search for genetic etiology of
psychiatric disorders, with potential for shaping clinical and
research practice.
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